MRO
60
4
URI
75
3
AVGO
32
5
DTE
65
4
CAH
61
3
PRGO
33
-6
ILMN
44
-3
AON
56
7
CSX
44
-3
ORCL
54
2
MAT
37
-2
EBAY
31
-3
ETN
78
3
NDAQ
55
2
PEP
50
-6
T
65
-4
PYPL
49
6
ALLE
32
4
WFC
74
2
AMP
57
3
MRO
60
4
URI
75
3
AVGO
32
5
DTE
65
4
CAH
61
3
PRGO
33
-6
ILMN
44
-3
AON
56
7
CSX
44
-3
ORCL
54
2
MAT
37
-2
EBAY
31
-3
ETN
78
3
NDAQ
55
2
PEP
50
-6
T
65
-4
PYPL
49
6
ALLE
32
4
WFC
74
2
AMP
57
3
Financhill
Back

Immunovant Stock Predictions

Something is Coming for America's Top Stock

Click here to learn its name and why.
Buy
83

IMVT
Immunovant

Last Price:
39.19
Seasonality Move:
-4.14%

7 Day Trial

ALL ACCESS PASS

$ 7

America's Cash Bubble Set to Burst on December 13, 2023

Watch His Free Video Here

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 143.5% based on the past 4 years of stock performance.
  • Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $39.19. The Score for IMVT is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
  • IMVT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 143.5% based on the past 4 years of stock performance.

Immunovant Stock Rating

Buy
83
Immunovant (IMVT) is a Buy

Is Immunovant overpriced?

  • Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • The current trend is moderately bullish and IMVT is experiencing slight selling pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
44.19
52-Week Low:
14.05

Prediction Charts

Market Cap:
5.67B
Price in USD:
39.19
Volume:
972.69K
Beta:
0.75

Technical Analysis

SMA50:
35.45
SMA100:
29.12
SMA200:
23.68
52-Wk Change:
161.79%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 39.19 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-20 34.28 33.80 35.09 33.66
Nov-21 33.27 32.96 33.90 32.95
Nov-22 33.30 32.68 34.08 32.36
Nov-24 32.63 33.42 34.15 32.49
Nov-27 33.42 33.54 33.70 31.84
Nov-28 34.52 36.01 36.81 32.34
Nov-29 36.18 38.24 40.00 36.16
Nov-30 38.81 39.11 40.90 38.47
Dec-1 39.35 40.55 40.66 38.14
Dec-4 39.91 40.81 40.94 39.00
Dec-5 40.45 39.93 40.84 39.63
Dec-6 39.65 39.02 40.12 38.33
Dec-7 39.15 40.25 40.40 38.98
Dec-8 39.63 39.19 40.26 38.57

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.22 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.